Screening for Gestational Diabetes Mellitus in Early Pregnancy: What Is the Evidence?
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The incidence of gestational diabetes mellitus (GDM) is increasing worldwide. This has a significant effect on the health of the mother and offspring. There is no doubt that screening for GDM between 24 and 28 weeks is important to reduce the risk of adverse pregnancy outcomes. However, there is no consensus about diagnosis and treatment of GDM in early pregnancy. In this narrative review on the current evidence on screening for GDM in early pregnancy, we included 37 cohort studies and eight randomized controlled trials (RCTs). Observational studies have shown that a high proportion (15–70%) of women with GDM can be detected early in pregnancy depending on the setting, criteria used and screening strategy. Data from observational studies on the potential benefit of screening and treatment of GDM in early pregnancy show conflicting results. In addition, there is substantial heterogeneity in age and BMI across the different study populations. Smaller RCTs could not show benefit but several large RCTs are ongoing. RCTs are also necessary to determine the appropriate cut-off for HbA1c in pregnancy as there is limited evidence showing that an HbA1c ≥6.5% has a low sensitivity to detect overt diabetes in early pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“There is no doubt that screening for GDM between 24 and 28 weeks is important to reduce the risk for adverse pregnancy outcomes such as large-for-gestational age infants (LGA) and preeclampsia [2,3].”
BackgroundHod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30007-2 · Cited by 558
Zhu, W.-W., Yang, H.-X., Wei, Y.-M., Yan, J., Wang, Z.-L., Li, X.-L., Wu, H.-R., Li, N., Zhang, M.-H., Liu, X.-H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1157 · Cited by 338 · cited 2×
“, 2013/China [14] Retrospective cohort study 14,039 All pregnant women without ODIP First antenatal visit (<24 weeks) FPG/China GDM diagnosis criteria 6 FPG groups (<4.”
BackgroundSweeting, A. N., Ross, G. P., Hyett, J., Molyneaux, L., Constantino, M., Harding, A. J., & Wong, J. (2016) · Diabetes Care · doi:10.2337/dc15-0433 · Cited by 263 · cited 12×
“An Australian study demonstrated also that early diagnosis and intervention had no effect on pregnancy outcomes [21].”
BackgroundInfluentialHughes, R. C. E., Moore, M. P., Gullam, J. E., Mohamed, K., & Rowan, J. (2014) · Diabetes Care · doi:10.2337/dc14-1312 · Cited by 238 · cited 6×
“). i st ies r rf r i sia (13.3%), 18 in Europe (39.1%), seven in America (15.6%), three in the Middle East (6.7%), four in Australia (8.9%), two in New Zealand (4.5”
BackgroundInfluentialEarly gestational diabetes screening in obese women: a randomized controlled trial
Harper, L. M., Jauk, V., Longo, S., Biggio, J. R., Szychowski, J. M., & Tita, A. T. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.12.021 · Cited by 121
Corrado, F., D’Anna, R., Cannata, M. L., Interdonato, M. L., Pintaudi, B., & Di Benedetto, A. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.03.006 · Cited by 96 · cited 1×
“Corrado, 2012/Italy [13] Retrospective study 738 Singleton pregnancies <13 weeks FTFPG/IADPSG criteria FTFPG vs.”
Background
Cited by
Mazumder, T., Akter, E., Rahman, S. M., Islam, M. T., & Talukder, M. R. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19052583 · Cited by 79
“Although the evidence regarding the benefits of early screening and treatment of GDM on pregnancy outcomes remains inconclusive, including evidence from small, randomised controlled trials, further large studies have been recommended among different population groups, including those from low- and middle-income countr…”
BackgroundHaque, M. M., Tannous, W. K., Herman, W. H., Immanuel, J., Hague, W. M., Teede, H., Enticott, J., Cheung, N. W., Hibbert, E., Nolan, C. J., et al. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102610 · Cited by 35
“There had been no previous large RCT of early GDM treatment 20 (as opposed to early GDM screening 21 ), and it remained unclear whether early treatment would be of bene fi t, or if the GDM diagnostic criteria applicable for 24 – 28 weeks ’ were appropriate for early pregnancy.”
BackgroundBastian, B., Smithers, L. G., Pape, A., Davis, W., Fu, K., & Francois, M. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111890 · Cited by 18
Bogdanet, D., Toth Castillo, M., Doheny, H., Dervan, L., Angel Luque-Fernandez, M., Halperin, J., O'Shea, P. M., & Dunne, F. P. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110023 · Cited by 6
Metadata
- Authors
- Raets, L., Beunen, K., & Benhalima, K.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-03-18
- Volume
- 10
- Issue
- 6
- Pages
- 1257
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W3139105653
- Cited by
- 60
- References
- 16
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for Gestational Diabetes Mellitus in Early Pregnancy: What Is the Evidence? https://app.cochat.ai/papers/10.3390/jcm10061257
- The paper
- Raets, L., Beunen, K., & Benhalima, K. (2021). Screening for Gestational Diabetes Mellitus in Early Pregnancy: What Is the Evidence? Journal of Clinical Medicine. https://doi.org/10.3390/jcm10061257
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.